The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM&C Saatchi Regulatory News (SAA)

Share Price Information for M&C Saatchi (SAA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 204.00
Bid: 204.00
Ask: 205.00
Change: 1.00 (0.49%)
Spread: 1.00 (0.49%)
Open: 208.00
High: 208.00
Low: 204.00
Prev. Close: 203.00
SAA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 update

2 Apr 2020 07:00

RNS Number : 5482I
M&C Saatchi PLC
02 April 2020
 

COVID-19 update

M&C Saatchi plc provides the following update on the impact of COVID-19.

Trading in the first two months of 2020 was in line with the Board's expectations. We began to feel the impact of COVD-19 in March, with a reduction in activity in several of our markets following government restrictions on movement and the consequent reduction in economic activity.

The Group's priorities since the start of the pandemic have been the safety of employees, the delivery of excellent work for clients, maintaining close controls on the cost base and the preservation of cash. The Board has been undertaking strenuous stress-testing of the financial models under different scenarios (and will continue to do so) and remains confident about the liquidity status of the Group for the foreseeable future. We would like to thank our employees for the courage, dedication and ingenuity they have shown during these past few weeks.

All Group companies continue to operate and serve our clients, with the majority of offices currently operating a remote working policy. Whilst we have seen a sharp drop in demand across the group, we continue to pitch for new business and there are still some areas where demand for our services remains steady, e.g. our talent and influencer businesses.

As a result, our performance was substantially weaker in March than in January and February. It is clear that COVID-19 will continue to have an impact on the business. At this stage, however, it is not possible to accurately predict the scale or duration of the impact. As a result, we are not providing financial guidance for 2020. We will provide an update when appropriate.

We are taking wide-ranging action to mitigate the financial impact of the crisis and maintain a strong liquidity position in anticipation of a further deterioration in the business environment.

The Group had approximately £45m of cash worldwide as at 23rd March 2020. This includes a fully drawn revolving credit facility (RCF) with NatWest of £36m, leaving a net cash position of £9m. Although the Group is in a net cash position, the RCF and cash is typically required for working capital purposes. The £36m RCF and £5m overdraft facility (which is undrawn), was recently extended through to 31 July 2021, and has a 2.5x Gross Borrowings / Adjusted EBITDA covenant and a 5x Adjusted PBIT / borrowing costs (interest cover) covenant. Despite the increased pressure on cash, the company forecasts it has sufficient liquidity and expects to be able to continue to operate within these covenant levels for the foreseeable future.

We are reducing costs in a number of areas, including the elimination of significant rent, IT and travel expenditure and reduced capital expenditure in the London head office. In addition, we have improved the Group's cashflow and working capital through deferrals of tax and rent through instituting a daily review of cash outflows and receipts and working with our clients to ensure payments are received on a timely basis.

Where appropriate, the Group is seeking to apply for additional government business support initiatives worldwide. We are focused on protecting our employees as much as possible and will be securing government support to furlough staff in the UK, the US and Australia. For a very large proportion of higher paid, non-furloughed staff we are reducing salaries. The Group's Board and senior management team have already committed to a 20% reduction in their salaries. We regretfully commenced consultation with a number of employees across the Group about possible redundancy before the recent escalation in the Covid-19 crisis and this process will continue.

Given the current circumstances, the Board has decided to suspend shareholder distributions until further notice. This includes the final dividend for the year ended 30 December 2019.

The Group expects to announce its Full Year Results for the year ended 31 December 2019 in May 2020 on completion of the 2019 audit.

--- end---

 

For further information please call:

 

M&C Saatchi +44 (0)20-7543-4500David Kershaw, Mickey Kalifa

 

Tulchan Communications +44 (0)20-7353-4200Tom Murray

 

Numis Securities +44 (0)20-7260-1000Nick Westlake, Hugo Rubinstein, NOMADCharles Farquhar, Corporate Broking

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTITMATMTMMMAM
Date   Source Headline
29th Sep 202210:47 amRNSForm 8.5 (EPT/RI)
29th Sep 20228:50 amRNSForm 8.5 (EPT/RI)
29th Sep 20227:00 amRNSUpdate on Acceptance Levels
28th Sep 20221:34 pmGNWForm 8.3 - Octopus Investments - M&C Saatchi plc
28th Sep 202210:26 amRNSForm 8.5 (EPT/RI)
28th Sep 20227:00 amRNSUpdate on Acceptance Levels
27th Sep 20224:19 pmRNSPublication of Supplemental Prospectus
27th Sep 20222:42 pmBUSForm 8.3 - M&C Saatchi PLC
27th Sep 20221:29 pmGNWForm 8.3 - Octopus Investments - M&C Saatchi plc
27th Sep 202210:07 amRNSForm 8.5 (EPT/RI)
27th Sep 20228:49 amRNSForm 8.5 (EPT/RI)
27th Sep 20227:00 amRNSUpdate on Acceptance Levels
26th Sep 20224:41 pmRNSSecond Price Monitoring Extn
26th Sep 20224:36 pmRNSPrice Monitoring Extension
26th Sep 20222:23 pmBUSForm 8.3 - M&C Saatchi PLC
26th Sep 20221:51 pmRNSADV Acceptance Levels and Rejection of ADV Offer
26th Sep 20221:13 pmGNWForm 8.3 - Octopus Investments - M&C Saatchi plc
26th Sep 202211:45 amRNSForm 8.5 (EPT/RI)
26th Sep 20227:00 amRNSUpdate on Acceptance Levels
23rd Sep 20223:19 pmBUSForm 8.3 - M&C Saatchi PLC
23rd Sep 20221:34 pmGNWForm 8.3 - Octopus Investments - M&C Saatchi plc
23rd Sep 20229:59 amRNSForm 8.5 (EPT/RI)
23rd Sep 20227:00 amRNSUpdate on Acceptance Levels
23rd Sep 20227:00 amRNSUpdate on Acceptance Levels
22nd Sep 20222:38 pmBUSForm 8.3 - M&C Saatchi PLC
22nd Sep 202210:28 amRNSForm 8.5 (EPT/RI)
22nd Sep 20227:00 amRNSUpdate on Acceptance Levels
21st Sep 202212:36 pmGNWForm 8.3 - Octopus Investments - M&C Saatchi plc
21st Sep 20229:05 amRNSForm 8.5 (EPT/RI)
20th Sep 20221:31 pmGNWForm 8.3 - Octopus Investments - M&C Saatchi plc
20th Sep 202210:23 amRNSForm 8.5 (EPT/RI)
20th Sep 202210:09 amGNWInvesco Ltd.: Form 8.3 - M&C Saatchi PLC
16th Sep 202212:57 pmGNWForm 8.3 - Octopus Investments - M&C Saatchi plc
16th Sep 20229:25 amRNSForm 8.5 (EPT/RI)
16th Sep 20229:03 amRNSForm 8.5 (EPT/RI)
15th Sep 20222:54 pmGNWForm 8.3 - Octopus Investments - M&C Saatchi plc
15th Sep 20221:11 pmRNSForm 8.3 - AdvancedAdvT Limited
15th Sep 202212:05 pmRNSForm 8.5 (EPT/RI)
15th Sep 20227:00 amRNSUpdate on Acceptance Levels
14th Sep 202212:40 pmGNWForm 8.3 - Octopus Investments - M&C Saatchi plc
14th Sep 202210:41 amRNSForm 8.5 (EPT/RI)
13th Sep 20223:55 pmGNWForm 8.3 - Octopus Investments - M&C Saatchi plc
13th Sep 20229:05 amRNSForm 8.5 (EPT/RI)
13th Sep 20227:00 amRNSContinued Rejection of ADV Offer
12th Sep 20222:51 pmRNSForm 8.3 - M&C Saatchi plc
12th Sep 20222:32 pmBUSForm 8.3 - M&C Saatchi PLC
12th Sep 20229:23 amRNSForm 8.5 (EPT/RI)
12th Sep 20228:38 amRNSForm 8.5 (EPT/RI)
9th Sep 20223:52 pmGNWForm 8.3 - Octopus Investments - M&C Saatchi plc
9th Sep 202212:31 pmRNSForm 8.5 (EPT/RI) - M&C Saatchi PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.